SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-063667
Filing Date
2024-03-08
Accepted
2024-03-08 16:17:00
Documents
14
Period of Report
2024-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d782153d8k.htm   iXBRL 8-K 23545
  Complete submission text file 0001193125-24-063667.txt   141577

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bntc-20240306.xsd EX-101.SCH 2885
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20240306_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20240306_pre.xml EX-101.PRE 10835
15 EXTRACTED XBRL INSTANCE DOCUMENT d782153d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 24734588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)